3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Triple Negative Breast Neoplasms
5
Stomach Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Adenocarcinoma
3
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Locally Advanced Gastric Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Childhood Solid Tumor
1
Breast Neoplasm Malignant Female
1
Brain Neoplasms
1
Advanced Solid Tumour
1
Advanced Rectal Cancer
1
Adjuvant Drug Therapy
1
Interventions
Cisplatin
4
Radiotherapy
3
Cetuximab
3
pembrolizumab
2
Surveys and Questionnaires
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
cemiplimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Docetaxel
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Capecitabine
×
30 days
×
Clear all
No trials found.